Electronic ISSN 2287-0237

VOLUME

CURRENT TREATMENT OF MALIGNANT MESOTHELIOMA

FEBRUARY 2017 - VOL.13 | REVIEWS ARTICLE

Malignant mesothelioma is a cancer of the mesothelium. Although mesothelioma is a rare malignancy, it has a poor prognosis. The incidence rate of malignant mesothelioma has been rising since the mid twentieth century century. Asbestos is the most common cause of mesothelioma. Chemotherapy combined with radiation therapy is currently the best choice of treatment and monoclonal antibody therapy is a new treatment option for the future. In the present study, we thoroughly reviewed the pathogenesis, clinical features, laboratory diagnosis, modalities of treatment, and clinical outcomes of this condition.

Keywords

malignant mesothelioma, chemotherapy for mesothelioma, asbestos, monoclonal antibody therapy

MEDIA
Figure 1
An example of peritoneal malignant mesothelioma is shown. Hematoxylin and eosin-stained sections demonstrate papillae (A) and sheets (B) of tumor cells. They have oval-shaped vesicular nuclei, visible nucleoli, and voluminous pale eosinophilic cytoplasm (C). Case courtesy of Prof. Shanop Shuangshoti, MD
SEARCH VOLUME & NUMBER
GO
RECENT VOLUME & NUMBER